| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 186.75B | 202.17B | 189.88B | 197.82B | 184.84B | 160.06B |
| Gross Profit | 25.32B | 30.34B | 25.76B | 28.44B | 27.71B | 25.79B |
| EBITDA | 22.61B | 26.01B | 23.13B | 24.34B | 22.93B | 22.10B |
| Net Income | 5.23B | 8.48B | 6.08B | 8.08B | 6.79B | 7.11B |
Balance Sheet | ||||||
| Total Assets | 193.98B | 207.19B | 197.76B | 191.74B | 178.40B | 172.62B |
| Cash, Cash Equivalents and Short-Term Investments | 22.73B | 22.21B | 26.27B | 28.72B | 22.34B | 21.57B |
| Total Debt | 8.26B | 7.28B | 10.07B | 7.75B | 9.37B | 13.94B |
| Total Liabilities | 70.52B | 72.53B | 70.28B | 71.29B | 67.31B | 69.39B |
| Stockholders Equity | 111.66B | 120.20B | 113.99B | 107.82B | 100.27B | 94.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.56B | -21.00M | 11.86B | 9.69B | 4.93B |
| Operating Cash Flow | 0.00 | 22.34B | 18.61B | 27.23B | 21.19B | 15.39B |
| Investing Cash Flow | 0.00 | -17.23B | -17.71B | -14.13B | -9.78B | -10.48B |
| Financing Cash Flow | 0.00 | -9.43B | -4.35B | -7.02B | -10.84B | -594.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥72.40B | 7.48 | 11.87% | 5.00% | -5.74% | -17.86% | |
74 Outperform | ¥71.93B | 9.43 | 5.20% | 3.67% | 6.47% | 40.87% | |
74 Outperform | ¥81.10B | 8.59 | ― | 3.85% | -1.01% | 8.57% | |
73 Outperform | ¥86.59B | 5.74 | ― | 4.95% | -1.72% | 8.59% | |
67 Neutral | ¥44.35B | 9.13 | 5.33% | 2.09% | 4.19% | 62.47% | |
64 Neutral | ¥62.63B | 6.23 | ― | 3.66% | -0.95% | 66.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |